length determinations using the Genescan software on an ABI 373A automatic sequencer. The procedure contains a PCR with one primer labelled with fluorescence dye.
For the statistical comparison of the distributions of CAG copies for the three samples, the p value from the exact procedure for contingency tables was calculated using StatXact's Monte Carlo approach with 1 000 000 replications. Thus the width of the 99% confidence interval for the p value could be reduced to 0-001 indicating that the p value given is exact at least to the second decimal.
The distribution of repeat sizes in the DRPLA gene in 47 male and female controls (94 chromosomes) varies between seven and 25 CAG copies with a maximum for [CAG] 15 in 29% of the chromosomes. In two cases (4%) homozygosity has been observed.
In 35 patients with questionable diagnoses of SCAl without expansions in the ataxin gene, seven to 21 CAG Turner's syndrome to determine the frequency of occult Y mosaicism.
As part of a total ascertainment study, 100 patients with Turner's syndrome were recruited from the four growth clinics and from adult Turner's syndrome clinics in Scotland.
The patients had the following karyotypes: 45,X in 48, 45,X/46,XiXq in 14, 45,X/46, Xr(X) in 10, 45,X/46,XX in seven, 45,X/ 46,XY in three, 45,X/46,Xi(Yp) in one, 45, X/46,X, + M in nine, and other karyotypes in eight.
DNA was extracted from peripheral lymphocytes of all patients by the same normal female (CEC, karyotype 46,XX) and PCR was carried out with nine sets of primers from the Y chromosome: PABY from the pseudoautosomal region which amplifies X and Y specific products of different sizes,'3 SRY1,'4 amelogenin'5 which amplifies X and Y specific products with a size difference, Y centromere,'6 sY85,'7 sYl17,'7 sYl46,'7 and sYl60, '7 Yl.1.'8 An additional primer set, sYl59,17 was used in patients who were positive with Y1.1. sY146 and sY160 were amplified in a multiplex reaction. All PCR products were resolved on 1-2% ethidium bromide stained agarose gels with both normal male and normal female controls on every gel.
Southern blotting of amplified DNA was also carried out on 84 of the patients who had been shown to be negative on direct visualisation of PCR products. Three primer sets were used initially, SRY1, Y centromere, and sY85, and a fourth XES1O/11'9 from the SRY gene was used on positive cases. Great care was taken to prevent contamination either by PCR products or genomic DNA when setting up the PCR reaction or running gels. All the experiments were carried out by the same female (46,XX karyotype). Separate pipettes were used for setting up the PCR and running gels, autoclaved solutions were used throughout, and all solutions were subjected to UV light for 10 minutes before use. The PCR products were run out in a separate laboratory one floor below that used for setting up the PCR. All doubtful cases were repeated and in two cases DNA was extracted from fresh blood samples. In five other cases different DNA samples were used.
Forty-six normal females were also screened using the SRY1 primers. In 40 of these the DNA was extracted by female laboratory staff and in six by a male scientist. After the finding of distal Yq sequences in patients 8 and 9, DNA from the mothers of both these patients was analysed for Y sequences. The mother of patient 8 was also positive for the same distal Yq sequences but not any other Y sequences and the mother of patient 9 was negative for all sequences tested.
Using the method of Southern blotting of amplified DNA, no patients were consistently positive for either sY85 or Y centromere sequences. Seventeen (17/84, 20%) Turner patients were positive for SRY1 sequences. The signals obtained varied in intensity and some were only visible after overnight exposure. Fourteen of the normal females (14/ 46, 30%) also showed positive signals using this primer set and the signals also varied in intensity. Only one of the samples extracted by a male scientist showed a positive signal.
A separate experiment using XES10/11 primers was then carried out for those patients and controls positive with the SRY1 primers. This set ofprimers is within the coding region for SRY but both primers are outside the HMG box. None of the samples showed positive signals. Serial dilution of male DNA showed that this method was able to detect 0-0001 jg male DNA.
Parental blood was available from all patients except patient 2 and the normal X chromosome was found to be maternal in origin for all the other patients.
We have shown that 9% (9/100) ofTurner's syndrome patients from a large unselected group have Y mosaicism, fewer than half of whom were identified by cytogenetic analysis. If patients with known Y material and unidentified markers are excluded from the analyses, 3-4% (3/87) of patients in this cohort were found to have unsuspected Y mosaicism. This is a slightly higher figure than that found in other studies to date (table 2) and probably reflects the fact that in this study multiple primer sets were used.
The present study highlights several different points. Firstly PCR can detect low level mosaicism missed by conventional cytogenetic analysis of relatively large numbers of cells, as in patient 7. Secondly, more than one area of the Y chromosome should be screened. Many of the previous studies have Direct visualisation of PCR products is rapid and sensitive, being capable of detecting 0-01% male DNA on a female DNA background. " Kocova et al'2 proposed an alternative strategy involving Southern blotting of amplified PCR products and found a surprisingly high incidence of patients positive for SRY sequences (6/18). In our study a similar number (17/84, 20%) ofpatients were positive with one set of SRY primers (SRY1) but all were negative for Y centromere and sY85 sequences and a similar percentage of normal female controls (14/46, 30%) were also positive using this method of analysis. Southern blotting of amplified DNA is extremely sensitive and very prone to contamination; however, great care was taken during all our experiments to prevent contamination. The positive results cannot be the result of contamination by genomic DNA as only one locus was affected and positive cases were retested on different DNA samples. Contamination by PCR products is also extremely unlikely, firstly because different pipettes were used to set up the PCR from those used to run out the products, the laboratory used to run out products was situated on a different floor from that used to set up the experiment, and, most importantly, the intensity of the positive signals seen in both the patients and controls varied from person to person.
The explanation for the positive signals in these patients and controls may be that the PCR primers used by Kocova et al2 and ourselves amplify a 270 bp sequence representing a DNA binding motif known as the high mobility group box (HMG box). This motif shares homology with a DNA binding motif present in non-histone proteins related to HMG1 and HMG227 and a DNA binding domain of hUBF (human upstream binding factor)27 and possibly other regions of the genome as well. It is possible that the signals detected in Turner's syndrome patients and normal female controls represent amplification of partially homologous sequences from these other regions. This theory is supported by our finding that patients and controls previously positive for SRY1 were negative using primer sets XES1O/ 1 which are still within the coding sequence for SRY but are located well outside the HMG box. These patients were negative in spite of the sensitivity of this particular assay which detects down to 0 0001 sg ofmale DNA. Southern blotting ofamplified DNA did not identify any patients not previously picked up using direct visualisation of PCR products and we would therefore not advocate its routine use.
However, it may be useful in confirming ambiguous results if great care is taken in the experimental methodology.
The clinical significance of occult Y mosaicism is unknown but in our experience PCR (without Southern blotting of amplified DNA) is more effective than routine cytogenetic analysis for its detection and may be further enhanced by screening multiple tissues.
